Access cutting-edge cystic fibrosis treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access cystic fibrosis specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cystic fibrosis treatment provided free
The goal of this Phase 2b clinical trial is to see if nebulized phage (BX004) can treat chronic Pseudomonas aeruginosa (PsA) lung infection in CF subjects. The primary goal is to see if 8 weeks of twice daily BX004 can reduce the amount of PsA in the sputum compared to placebo (on top of background CF therapy).
Sponsor: BiomX Ltd
Check if you qualify for this cystic fibrosis clinical trial in Birmingham, AL
If you're searching for cystic fibrosis treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cystic fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.